RALOXIFENE vs TAMOXIFEN CITRATE

Compare RALOXIFENE (Raloxifene Hydrochloride) and TAMOXIFEN CITRATE (SOLTAMOX) — clinical data, side effects, and patient experiences.

RALOXIFENE

Raloxifene Hydrochloride, Evista · SERM

How it works

12.1 Mechanism of Action Raloxifene is an estrogen agonist/antagonist, commonly referred to as a selective estrogen receptor modulator (SERM). The biological actions of raloxifene ...

Approved for

1 INDICATIONS AND USAGE Raloxifene hydrochloride tablet

reduction of the risk of recurrence of breast cancer

or reduction of risk of noninvasive breast cancer. ( 1.3 ) 1.1 Treatment and Prevention of Osteoporosis in Postmenopausal Women Raloxifene hydrochloride tablets

USP are indicated for the treatment and prevention of osteoporosis in postmenopausal women [see Clinical Studies (14.1

OralTablet

TAMOXIFEN CITRATE

SOLTAMOX, Nolvadex · SERM

How it works

12.1 Mechanism of Action Tamoxifen is an estrogen agonist/antagonist. Tamoxifen competes with estrogen for binding to the estrogen receptor, which can result in a decrease in estro...

Approved for

following breast surgery and radiation

OralTablet

Quick Comparison

RALOXIFENETAMOXIFEN CITRATE

Drug Class

SERM

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

RALOXIFENE

Nausea

1-10%

Falls

1-10%

Drug Not Working

1-10%

Limb Pain

1-10%

Joint Pain

1-10%

Dizziness

1-10%

Fatigue

1-10%

Headache

1-10%

TAMOXIFEN CITRATE

Fatigue

>10%

Nausea

1-10%

Joint Pain

1-10%

Diarrhea

1-10%

Vomiting

1-10%

Shortness of Breath

1-10%

Dizziness

1-10%

Headache

1-10%

FDA Warnings

RALOXIFENE

5 WARNINGS AND PRECAUTIONS Venous Thromboembolism: Increased risk of deep vein thrombosis, pulmonary embolism, and retinal vein thrombosis
1 ) Death Due to Stroke: Increased risk of death due to stroke occurred in a trial in postmenopausal women with documented coronary heart disease or at increased risk for major coronary events
No increased risk of stroke was seen in this trial
Consider risk-benefit balance in women at risk for stroke

TAMOXIFEN CITRATE

5 WARNINGS AND PRECAUTIONS Uterine malignancies: Promptly evaluate abnormal vaginal bleeding in a woman with current or past tamoxifen use
1 ) Thromboembolic events: Risk increases with coadministered chemotherapy
For treatment of breast cancer, consider risks and benefits in patients with a history of thromboembolic events
Advise females of reproductive potential of the potential risk to a fetus and to use effective contraception

Clinical Trial Data

No head-to-head clinical studies found for RALOXIFENE vs TAMOXIFEN CITRATE.

RALOXIFENE vs TAMOXIFEN CITRATE: What You Should Know

Key Differences

Both RALOXIFENE and TAMOXIFEN CITRATE belong to the SERM class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

RALOXIFENE carries 4 FDA warnings. TAMOXIFEN CITRATE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

RALOXIFENE HYDROCHLORIDE vs TAMOXIFEN CITRATE→RALOXIFENE vs RALOXIFENE HYDROCHLORIDE→TAMOXIFEN CITRATE vs TOREMIFENE CITRATE→RALOXIFENE vs TOREMIFENE CITRATE→RALOXIFENE vs TERIPARATIDE→RALOXIFENE vs ZOLEDRONIC ACID→

Loading comparison data...

RALOXIFENE vs TAMOXIFEN CITRATE

Compare RALOXIFENE (Raloxifene Hydrochloride) and TAMOXIFEN CITRATE (SOLTAMOX) — clinical data, side effects, and patient experiences.

RALOXIFENE

Raloxifene Hydrochloride, Evista · SERM

How it works

12.1 Mechanism of Action Raloxifene is an estrogen agonist/antagonist, commonly referred to as a selective estrogen receptor modulator (SERM). The biological actions of raloxifene ...

Approved for

1 INDICATIONS AND USAGE Raloxifene hydrochloride tablet

reduction of the risk of recurrence of breast cancer

or reduction of risk of noninvasive breast cancer. ( 1.3 ) 1.1 Treatment and Prevention of Osteoporosis in Postmenopausal Women Raloxifene hydrochloride tablets

USP are indicated for the treatment and prevention of osteoporosis in postmenopausal women [see Clinical Studies (14.1

OralTablet

TAMOXIFEN CITRATE

SOLTAMOX, Nolvadex · SERM

How it works

12.1 Mechanism of Action Tamoxifen is an estrogen agonist/antagonist. Tamoxifen competes with estrogen for binding to the estrogen receptor, which can result in a decrease in estro...

Approved for

following breast surgery and radiation

OralTablet

Quick Comparison

RALOXIFENETAMOXIFEN CITRATE

Drug Class

SERM

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

RALOXIFENE

Nausea

1-10%

Falls

1-10%

Drug Not Working

1-10%

Limb Pain

1-10%

Joint Pain

1-10%

Dizziness

1-10%

Fatigue

1-10%

Headache

1-10%

TAMOXIFEN CITRATE

Fatigue

>10%

Nausea

1-10%

Joint Pain

1-10%

Diarrhea

1-10%

Vomiting

1-10%

Shortness of Breath

1-10%

Dizziness

1-10%

Headache

1-10%

FDA Warnings

RALOXIFENE

5 WARNINGS AND PRECAUTIONS Venous Thromboembolism: Increased risk of deep vein thrombosis, pulmonary embolism, and retinal vein thrombosis
1 ) Death Due to Stroke: Increased risk of death due to stroke occurred in a trial in postmenopausal women with documented coronary heart disease or at increased risk for major coronary events
No increased risk of stroke was seen in this trial
Consider risk-benefit balance in women at risk for stroke

TAMOXIFEN CITRATE

5 WARNINGS AND PRECAUTIONS Uterine malignancies: Promptly evaluate abnormal vaginal bleeding in a woman with current or past tamoxifen use
1 ) Thromboembolic events: Risk increases with coadministered chemotherapy
For treatment of breast cancer, consider risks and benefits in patients with a history of thromboembolic events
Advise females of reproductive potential of the potential risk to a fetus and to use effective contraception

Clinical Trial Data

No head-to-head clinical studies found for RALOXIFENE vs TAMOXIFEN CITRATE.

RALOXIFENE vs TAMOXIFEN CITRATE: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.